Cargando…
The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic syndrome
Autores principales: | Stepanov, Vanesa, Stankov, Karmen, Mikov, Momir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506336/ http://dx.doi.org/10.1186/2050-6511-13-S1-A7 |
Ejemplares similares
-
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
por: Ðanić, Maja, et al.
Publicado: (2018) -
Role of the bile acid receptor TGR5 (Gpbar-1) in liver damage and regeneration
por: Keitel, Verena, et al.
Publicado: (2014) -
Differences in the use of medicines for peptic ulcer and gastro-esophageal reflux disease between Serbia, Croatia and Sweden
por: Stanimirov, Bojan, et al.
Publicado: (2012) -
Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
por: Jadhav, Kavita, et al.
Publicado: (2018) -
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
por: Pavlović, Nebojša, et al.
Publicado: (2018)